eSanjeevani

In one line

eSanjeevani is India's national telemedicine service, run by the Ministry of Health & Family Welfare — and it is really two products wearing one name, each attacking a different kind of scarcity.

The two arms, and why the distinction matters

Most write-ups say "eSanjeevani is India's telemedicine platform" and stop. That sentence hides the actual design insight.

eSanjeevani AB-HWC — provider to provider. A patient walks into an Ayushman Bharat Health & Wellness Centre and sits with a community health officer. That officer connects to a doctor at a district hub. It's a hub-and-spoke model: the patient is not alone with a phone, they're with a trained health worker who can take a blood pressure, describe the wound, and carry out what the remote doctor advises.

eSanjeevani OPD — patient to doctor. The familiar thing: a citizen, at home, consults a doctor directly.

Now the point. These solve different scarcity problems:

• OPD solves access — you're far from a clinic, or can't take a day off work.
• AB-HWC solves specialist maldistribution — the clinic exists and is staffed, but the specialist is 200 km away and always will be.

India's shortage was never only that people can't reach a building. It's that expertise is concentrated in cities while need is distributed everywhere. The hub-and-spoke arm addresses that directly: it multiplies a scarce specialist across many sites without pretending a smartphone can replace hands.

Why hub-and-spoke is quietly the smarter model

Direct-to-consumer telemedicine has a ceiling that's easy to miss when it's going well. A doctor on a video call cannot palpate an abdomen, check a pupil, or hear a murmur. They depend entirely on what the patient can describe — and the patients with the worst outcomes are frequently the ones least able to describe symptoms precisely.

Put a health worker in the room and the ceiling lifts. The remote specialist gets real vitals, a competent examination, and a colleague who can execute the plan. That's a categorically better consultation, and it's why the AB-HWC arm reaches people that a pure app never would — including those without a smartphone, reliable data, or the literacy that an app silently assumes.

If you take one design lesson from eSanjeevani: the last mile is often a person, not an interface.

Where it sits in the stack

eSanjeevani predates much of ABDM and grew explosively during COVID-19, which shapes how it fits:

• Clinicians on it are the workforce the HPR exists to verify — remote consultation is exactly the setting where "is this a real doctor?" stops being answerable by looking around the room.
• It is a government-run service, whereas UHI is an open network any provider can join. One is a destination; the other is infrastructure. They're complementary answers to overlapping questions, and India is running both.

The honest caveats

Volume is not outcome. eSanjeevani's consultation counts are enormous and get quoted constantly. A consultation delivered is not a condition treated. The literature on telemedicine is much stronger on access and convenience than on hard clinical endpoints, and India-specific outcome evidence at this scale is still thin.

Continuity is the hard part. A teleconsultation that produces advice but no linked record is an episode, not care. The value compounds only when what happened on the call lands in the patient's longitudinal record — which is precisely what ABDM's consent-governed exchange is for. That integration, not the video call, is where the long-term payoff lives.